Patriot Financial Group Insurance Agency’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,788
| Closed | -$206K | – | 514 |
|
|
2024
Q3 | $206K | Hold |
1,788
| – | – | 0.03% | 461 |
|
|
2024
Q2 | $246K | Sell |
1,788
-70
| -4% | -$9.64K | 0.04% | 411 |
|
|
2024
Q1 | $256K | Buy |
1,858
+20
| +1% | +$2.76K | 0.04% | 402 |
|
|
2023
Q4 | $242K | Buy |
1,838
+3
| +0.2% | +$395 | 0.05% | 382 |
|
|
2023
Q3 | $206K | Buy |
+1,835
| New | +$206K | 0.04% | 414 |
|
|
2023
Q1 | – | Sell |
-2,094
| Closed | -$250K | – | 476 |
|
|
2022
Q4 | $250K | Buy |
+2,094
| New | +$250K | 0.03% | 352 |
|
|
2022
Q3 | – | Sell |
-78
| Closed | -$8K | – | 1382 |
|
|
2022
Q2 | $8K | Sell |
78
-13
| -14% | -$1.33K | ﹤0.01% | 1338 |
|
|
2022
Q1 | $9K | Buy |
91
+52
| +133% | +$5.14K | ﹤0.01% | 1404 |
|
|
2021
Q4 | $3K | Sell |
39
-50
| -56% | -$3.85K | ﹤0.01% | 1868 |
|
|
2021
Q3 | $9K | Buy |
89
+23
| +35% | +$2.33K | ﹤0.01% | 1517 |
|
|
2021
Q2 | $6K | Sell |
66
-16
| -20% | -$1.46K | ﹤0.01% | 1595 |
|
|
2021
Q1 | $8K | Sell |
82
-22
| -21% | -$2.15K | ﹤0.01% | 1430 |
|
|
2020
Q4 | $10K | Sell |
104
-6
| -5% | -$577 | ﹤0.01% | 1228 |
|
|
2020
Q3 | $11K | Buy |
110
+5
| +5% | +$500 | ﹤0.01% | 1007 |
|
|
2020
Q2 | $13K | Buy |
105
+20
| +24% | +$2.48K | 0.01% | 886 |
|
|
2020
Q1 | $7K | Buy |
+85
| New | +$7K | ﹤0.01% | 980 |
|